DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: Results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study

Cancer

Volumn 92, Issue 2, 2001, Pages 294-302

  Russo, Antonio ^a,d   Bazan, Viviana ^a   Migliavacca, Manuela ^a   Tubiolo, Carla ^a   Macaluso, Marcella ^a   Zanna, Ines ^a   Corsale, Simona ^a   Latteri, Federica ^a   Valerio, Maria Rosaria ^a   Pantuso, Gianni ^a   Morello, Vincenza ^a   Dardanoni, Gabriella ^b   Latteri, Mario Adelfio ^a   Colucci, Giuseppe ^c   Tomasino, Rosa Maria ^a   Gebbia, Nicola ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Epidemiological Observatory Center of Sicilian Region   (Italy)

^c NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^d NONE   (Italy)

Author keywords

DNA ploidy; Gastric carcinoma; K ras 2; Prognosis; S phase fraction; Staging

Indexed keywords

CELL DNA;

ANEUPLOIDY; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE MUTATION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MOLECULAR CLONING; ONCOGENE K RAS; PLOIDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; ANEUPLOIDY; CARCINOMA; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; GASTRECTOMY; GENES, RAS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; S PHASE; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035878802     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010715)92:2<294::AID-CNCR1322>3.0.CO;2-9     Document Type: Article

References (39)

1. Stomach cancer
2. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal type carcinoma
3. The clonal evolution of tumor cell populations
4. Cancer-susceptibility genes. Gate-keepers and caretakers
5. Prognostic value of DNA flow cytometry in stomach cancer: A 5-year prospective study
6. Flow cytometric DNA ploidy, p53, PCNA, and c-erbB-2 protein expressions as predictors of survival in surgically resected gastric cancer patients
7. Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma
8. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma
9. Kirsten ras mutations in patients with colorectal cancer: The multicenter "RASCAL" study
10. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung
11. Molecular biology in gastric cancer
12. Vimentin expression, proliferating cell nuclear antigen and flow cytometric factors. Prognostic role in breast cancer
13. Mathematical analysis of DNA distributions derived from flow microfluorometry
14. Numerical compensation for the effects of cell clumping on DNA histograms
15. Direct identification of each specific mutation in codon 12 and 13 of ci-ki-ras2 by SSCP analysis
16. 'Cold SSCP': A simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses
17. Nonparametric estimation for incomplete observations
18. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
19. Regression models and life tables
20. Cytogenetic findings in eleven gastric carcinomas
21. Cytogenetic study of 11 gastric adenocarcinomas
22. Proliferative activity and malignancy in human gastric cancers. Significance of the proliferation rate and its clinical application
23. The value of flow cytometric analysis in patients with gastric cancer
24. Comparison of DNA ploidy and S-phase fraction with prognostic factors in gastric cancer
25. DNA content by flow cytometry in gastric carcinoma: Pathology, ploidy and prognosis
26. DNA aneuploidy by flow cytometry is an independent prognostic factor in gastric cancer
27. DNA ploidy, Ki-67 and p53 as indicators of lymph node metastasis in early gastric carcinoma
28. Pathology and ploidy in the prognosis in gastric cancer with no extranodal metastasis
29. Flow cytometric analysis of paraffin-embedded material in human gastric cancer
30. FLow cytometry as a predictive indicator in patients with operable gastric cancer
31. Clinical significance of DNA ploidy pattern in stage III gastric cancer
32. Absence of ras gene mutations in early gastric carcinomas
33. Activation of c-K-ras mutations in human gastrointestinal tumors
34. Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases
35. Loss of heterozygosity and K-ras gene mutations in gastric cancer
36. Point mutation of c-Ki-ras oncogene in gastric adenoma and adenocarcinoma with tubular differentiation
37. K-ras activation in gastric epithelial tumors in Japanese
38. Mutation of ras oncogene in gastric adenocarcinoma: Association with histological phenotype